Nitric oxide synthase catalyzes the pyridine nucleotide-dependentoxidation of
L-arginine tonitric oxide and
L-citrulline. It is a specializedcytochro
me P
450 monooxygenase that is sensitive toinhibitionby i
midazole. Steady-state kinetic studies on reco
mbinant hu
maninducible nitric oxide synthase (rH-iNOS) de
monstrate that i
midazole and 1-phenyli
midazole are co
mpetitiveand reversible inhibitors versus
L-arginine. Structure-activity relationship and pHdependence studies on the inhibition suggest that theneutral for
m of i
midazole
may be the preferred species and that theonly
modifications allowed withoutthe loss of inhibition are at the N-1 position of i
midazole.Optical spectrophoto
metric studies of rH-iNOS with i
midazole and 1-phenyli
midazole yielded type II differencespectra exhibiting
Kd values of 63± 2 and 28 ± 3
mages/entities/
mgr.gif">M, respectively. These values were in goodagree
ment with the steady-state
Ki of95± 10 and 38 ± 4
mages/entities/
mgr.gif">M, respectively, and confir
ms the site ofbinding is at the sixth axial ligand of thehe
me. I
midazole (2.2
mM) also perturbed the
Kd of
L-arginine fro
m 3.03 ± 0.45to 209 ± 10
mages/entities/
mgr.gif">M. Theobserved increase in the
Kd for
L-arginine is consistent with i
midazole being a co
mpetitiveinhibitor versus
L-arginine. The IC
50 values of i
midazoleand 1-phenyli
midazole were lower in the absence ofexogenousBH
4, and both inhibitors also co
mpetitively inhibited theBH
4-dependent activation of the enzy
me.Thesedata taken together suggest that the
L-arginine, dioxygen,and the BH
4 binding sites are in closeproxi
mityin rH-iNOS. Further
more, these studies de
monstrate the usefulnessof i
midazole co
mpounds as activesite probes for reco
mbinant hu
man iNOS.